Represented William F. Perkins, the examiner appointed in the Chapter 11 cases of HomeGold Financial Inc., HomeGold Inc. and Carolina Investors Inc., pending in the United States Bankruptcy Court for the District of South Carolina, Columbia Division. HomeGold and HomeGold Financial were collectively a subprime mortgage lender funded by the sales to the public of the subordinated debentures of Carolina Investors Inc. Carolina Investors effectively operated as an unregulated bank, and the examiner was appointed to determine the cause of the collapse of the HomeGold/Carolina Investor entities and to determine the claims of the three debtor estates against third parties. The firm assisted the examiner in an extensive series of interviews of the officers and directors of the HomeGold/Carolina Investor entities; review of the relevant documents associated with the failure of the HomeGold/Carolina Investor entities; research and analysis of the claims of the debtors against third parties; preparation of three reports of the examiner; and, advising the examiner, whose powers were expanded to include operation of the debtor entities, on the orderly liquidation of the debtors and the formulation and preparation of a plan and all associated documents.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Implementation of Brownfields Agreement for Kim's Greensboro Real Estate, LLC
Represented Kim's Greensboro Real Estate, LLC in the redevelopment of property that was the former site of a manufacturing plant for general more
In re Southwest Hospital
Represented creditors' committee and then plan trustee of Southwest Hospital and Medical Center Inc. in connection with the sale of an Atlanta more
Real estate investment and development for an international hotel company
Represented an international hotel company in the acquisition and development of hotel and resort properties in the Americas and the Caribbean, more
Acquisition of an international biotechnology laboratory by a clinical laboratory network
The firm assisted one of the world's largest clinical laboratory networks in its acquisition of an international biotechnology more